1. Molecular basis of antibody binding to mucin glycopeptides in lung cancer
   JIN QU et al, 2016, International Journal of Oncology CrossRef
2. Preferential Localization of MUC1 Glycoprotein in Exosomes Secreted by Non-Small Cell Lung Carcinoma Cells
   Deng Pan et al, 2019, International Journal of Molecular Sciences CrossRef
3. Lectin approaches for glycoproteomics in FDA-approved cancer biomarkers
   Haitham A Badr et al, 2014, Expert Review of Proteomics CrossRef
4. Nonspecific nuclear uptake of anti-MUC1 aptamers by dead cells: the role of cell viability monitoring in aptamer targeting of membrane-bound protein cancer biomarkers
   Shane Patrick Flanagan et al, 2021, Analytical Methods CrossRef
5. An antibody‐drug conjugate targeting a GSTA glycosite‐signature epitope of MUC1 expressed by non‐small cell lung cancer
   Deng Pan et al, 2020, Cancer Medicine CrossRef
6. PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells
   Xinru Wei et al, 2017, OncoImmunology CrossRef
7. Epitopes of MUC1 Tandem Repeats in Cancer as Revealed by Antibody Crystallography: Toward Glycopeptide Signature-Guided Therapy
   Dapeng Zhou et al, 2018, Molecules CrossRef
8. Separation and detection of minimal length glycopeptide neoantigen epitopes centering the GSTA region of MUC1 by liquid chromatography/mass spectrometry
   Dapeng Zhou et al, 2020, Rapid Communications in Mass Spectrometry CrossRef
9. Galectin-1 binds mucin in human trophoblast
   Žanka Bojić-Trbojević et al, 2014, Histochemistry and Cell Biology CrossRef
10. Comparative ligand structural analytics illustrated on variably glycosylated MUC1 antigen–antibody binding
    Christopher B Barnett et al, 2020, Beilstein Journal of Organic Chemistry CrossRef